Mckesson (MCK) Capital Expenditures Growth (1y) (2010 - 2026)
Mckesson (MCK) Capital Expenditures Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 105.15 Bn | 101.18 Bn | 4.04 Bn | -77.16% |
| 2 | Cencora | 60.58 Bn | 58.40 Bn | 3.59 Bn | 28.33% |
| 3 | Cardinal Health | 53.81 Bn | 49.87 Bn | 2.50 Bn | 15.87% |
| 4 | Henry Schein | 9.71 Bn | 9.57 Bn | 1.07 Bn | -19.35% |
| 5 | Akso Health | 3.28 Bn | 3.28 Bn | - | - |
| 6 | 111 | 651.73 Mn | 572.63 Mn | 23.58 Mn | - |
| 7 | Accendra Health | 248.02 Mn | -88.86 Mn | 278.03 Mn | -9.06% |
| 8 | Edap Tms | 230.14 Mn | 215.14 Mn | 8.15 Mn | 780.43% |
| 9 | VitaNova Life Sciences | 11.51 Mn | 11.01 Mn | 316,343.00 | - |
| 10 | Cosmos Health | 9.57 Mn | 7.41 Mn | 1.38 Mn | -9.03% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -77.16% |
| Dec 31, 2025 | 331.03% |
| Sep 30, 2025 | -50.28% |
| Jun 30, 2025 | 27.87% |
| Mar 31, 2025 | 300.00% |
| Dec 31, 2024 | -145.31% |
| Sep 30, 2024 | 178.46% |
| Jun 30, 2024 | 32.61% |
| Mar 31, 2024 | 183.51% |
| Dec 31, 2023 | -68.00% |
| Sep 30, 2023 | 1,183.33% |
| Jun 30, 2023 | -35.21% |
| Mar 31, 2023 | -585.00% |
| Dec 31, 2022 | 488.24% |
| Sep 30, 2022 | -122.22% |
| Jun 30, 2022 | 7.58% |
| Mar 31, 2022 | -87.34% |
| Dec 31, 2021 | -71.43% |
| Sep 30, 2021 | -79.07% |
| Jun 30, 2021 | 46.67% |